Patent Assignment
Reel/Frame 048297/0090
Assignment of Assignor's Interest
Recorded: 2019-02-11
Pages: 8
Assignor
NEUMAN, LINDA L.
Executed: 2017-02-22
Assignee
SUNESIS PHARMACEUTICALS, INC.
395 OYSTER POINT BOULEVARD, SUITE 400, SOUTH SAN FRANCISCO, CALIFORNIA, 94080
Covered Property
(1)
Succinate Forms and Compositions of Bruton's Tyrosine Kinase Inhibitors
Patent:
11,174,243 →
Application:
16/319,506 →
Publication:
US 2021/0032218
PCT:
PCT/US2017/012637 ↗
Related Assignments
(4)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Feb 27, 2017
From: NEUMAN, LINDA L.
To: SUNESIS PHARMACEUTICALS, INC.
Reel/Frame 041378/0397 →
Assignment of Assignor's Interest
Feb 11, 2019
From: MACPHEE, J. MICHAEL
To: BIOGEN MA INC.
Reel/Frame 048297/0119 →
Change of Name
Dec 9, 2021
From: SUNESIS PHARMACEUTICALS, INC.
To: VIRACTA THERAPEUTICS, INC.
Reel/Frame 058741/0187 →
Intellectual Property Security Agreement
Jan 23, 2025
From: VIRACTA THERAPEUTICS, INC.
To: OXFORD FINANCE LLC, AS COLLATERAL AGENT
Reel/Frame 070000/0010 →